Autoimmune disease risk gene ANKRD55 promotes TH17 effector function through metabolic modulation
Journal of Experimental Medicine · 03.11.2025 · 222 (11)
DOI: 10.1084/jem.20250185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 11.09.2025. Verfasst von Jinjin Xu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Center for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School , Boston, MA, USA. Hauptthemen laut MEDLINE: Th17 Cells, Autoimmune Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The Leona M. and Harry B. Helmsley Charitable Trust, NIDDK NIH HHS, National Metabolomics Data Repository.
Abstract (Originalsprache)
Genome-wide association studies (GWAS) have linked the locus encoding ankyrin repeat domain 55 (ANKRD55) with numerous autoimmune diseases; however, its biological function and role in inflammation are unclear. Here, we demonstrate that Ankrd55-deficient mice are protected from T cell–mediated colitis but are more susceptible to Citrobacter rodentium infection. Mechanistically, Ankrd55 deletion impairs CD4+ T cell proliferation and reduces effector cytokine production in T helper 17 (TH17) cells in a cell-intrinsic manner. ANKRD55 is associated with mitochondria, and its loss is associated with impaired mitochondrial respiration and activation of the LKB1 pathway. Consistently, IL-17 production can be rescued by the deletion of LKB1 in Ankrd55-deficient T cells. Altogether, our study implicates the protein ANKRD55 as a functional modulator of T cell metabolism that directly impacts TH17 responses, highlighting it as a potential target across multiple autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School , Boston, MA, USA.
- Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Broad Institute of MIT and Harvard , Cambridge, MA, USA.
- Department of Systems Biology, Harvard Medical School, Boston, MA, USA.
- Department of Chemistry, Institute for Medical Engineering & Science and Koch Institute for Integrative Cancer Research, MIT, Cambridge, MA, USA.
- Ragon Institute of MGH, MIT and Harvard , Cambridge, MA, USA.
ORCID-Profile: Jinjin Xu, Lingjia Kong, Elizabeth A Creasey, Sneha Rath, Lei Deng, Julian Avila-Pacheco, Chenhao Li, Blayne A Oliver, Tyler T Dao, Angela R Shih, Mark J Daly, Alex K Shalek, Clary B Clish, Daniel B Graham, Jacques Deguine, Ramnik J Xavier
Förderung
- The Leona M. and Harry B. Helmsley Charitable Trust
- NIDDK NIH HHS
- National Metabolomics Data Repository
- Metabolomics Consortium Coordinating Center
- NIH HHS
- Common Fund Data Ecosystem
- National Institutes of Health
Zitieren
APA
Xu, J., Kong, L., Creasey, E. A., Rath, S., Deng, L., Avila-Pacheco, J., Li, C., Oliver, B. A., Dao, T. T., Shih, A. R., Daly, M. J., Shalek, A. K., Clish, C. B., Graham, D. B., Deguine, J., & Xavier, R. J. (2025). Autoimmune disease risk gene ANKRD55 promotes TH17 effector function through metabolic modulation. Journal of Experimental Medicine, 222(11). https://doi.org/10.1084/jem.20250185
Vancouver
Xu J, Kong L, Creasey EA, Rath S, Deng L, Avila-Pacheco J, et al. Autoimmune disease risk gene ANKRD55 promotes TH17 effector function through metabolic modulation. Journal of Experimental Medicine. 2025;222(11). doi:10.1084/jem.20250185
BibTeX
@article{Xu2025,
author = {Xu, Jinjin and Kong, Lingjia and Creasey, Elizabeth A and Rath, Sneha and Deng, Lei and Avila-Pacheco, Julian and Li, Chenhao and Oliver, Blayne A and Dao, Tyler T and Shih, Angela R and Daly, Mark J and Shalek, Alex K and Clish, Clary B and Graham, Daniel B and Deguine, Jacques and Xavier, Ramnik J},
title = {Autoimmune disease risk gene ANKRD55 promotes TH17 effector function through metabolic modulation},
journal = {Journal of Experimental Medicine},
year = {2025},
volume = {222},
number = {11},
doi = {10.1084/jem.20250185}
}
EUVIMED